Future Medicinal Chemistry
Volume 14, 2022 - Issue 8
Research Article
Quinazoline-Based Analog of Adenine As an Antidote Against MLL-rearranged Leukemia Cells: Synthesis, Inhibition Assays and Docking Studies
Corentin Bon1 Epigenetic Chemical BiologyDepartment of Structural Biology and ChemistryCentre National de la Recherche Scientifique–Institut Pasteur UMR3523Paris75015France;2 Ecole Doctorale MédicamentToxicologieChimieImageriesUniversité de ParisSorbonne Paris CitéParisFrance
https://orcid.org/0000-0002-6198-239X
https://orcid.org/0000-0002-6198-239X, , Nemanja Djokovic3 Department of Pharmaceutical ChemistryFaculty of PharmacyUniversity of BelgradeVojvode Stepe 450Belgrade11000Serbiahttps://orcid.org/0000-0001-9972-3492
https://orcid.org/0000-0001-9972-3492, Dusan Ruzic3 Department of Pharmaceutical ChemistryFaculty of PharmacyUniversity of BelgradeVojvode Stepe 450Belgrade11000Serbiahttps://orcid.org/0000-0002-0546-8265
https://orcid.org/0000-0002-0546-8265, , , , , Ludovic Halby1 Epigenetic Chemical BiologyDepartment of Structural Biology and ChemistryCentre National de la Recherche Scientifique–Institut Pasteur UMR3523Paris75015Francehttps://orcid.org/0000-0002-7988-7542
https://orcid.org/0000-0002-7988-7542, Katarina Nikolic3 Department of Pharmaceutical ChemistryFaculty of PharmacyUniversity of BelgradeVojvode Stepe 450Belgrade11000Serbiahttps://orcid.org/0000-0002-3656-9245
https://orcid.org/0000-0002-3656-9245 & Paola B Arimondo1 Epigenetic Chemical BiologyDepartment of Structural Biology and ChemistryCentre National de la Recherche Scientifique–Institut Pasteur UMR3523Paris75015FranceCorrespondence[email protected]
https://orcid.org/0000-0001-5175-4396
https://orcid.org/0000-0001-5175-4396 show all